August 2023 - BETACH3

1 min read

ENGLISH

Betaine as a neuroprotective therapy in multiple sclerosis

1 year ago admin

Sarah Sternbach, Jennifer McDonough Abstract This chapter provides an in-depth look at the compound betaine and its relevance to multiple sclerosis (MS). MS...

Month: August 2023

Betaine as a neuroprotective therapy in multiple sclerosis

COVID‐19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence

Betaine postpones hyperglycemia-related senescence in ovarian and testicular cells: Involvement of RAGE and β-galactosidase

Associations of dietary choline and betaine with all-cause mortality: a prospective study in a large Swedish cohort

Betaine attenuates age-related suppression in autophagy via Mettl21c/p97/VCP axis to delay muscle loss

Betaine as a neuroprotective therapy in multiple sclerosis

You may have missed

COVID‐19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence

Betaine postpones hyperglycemia-related senescence in ovarian and testicular cells: Involvement of RAGE and β-galactosidase

Associations of dietary choline and betaine with all-cause mortality: a prospective study in a large Swedish cohort

Betaine attenuates age-related suppression in autophagy via Mettl21c/p97/VCP axis to delay muscle loss